Close Menu

NEW YORK (GenomeWeb) — HTG Molecular Diagnostics said after the close of the market on Wednesday that it has signed a sales agreement with Cowen for the sale from time to time of $40 million of HTG's common stock.

The shares will be sold to or through Cowen though HTG is not obligated to sell any shares under the agreement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.